HARVARD BIOSCIENCE INC — Director's Dealing 2013

Nov 18, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2013-11-18

Reporting Person: Duchemin Jeffrey (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-11-18	Stock option (right to buy)	$4.31	A	500000	Acquired	2023-11-18	Common Stock, par value $0.01 per share (500000)	Direct

Footnotes

F1: The option shares vest in full three years from the date of grant.